// App-Quantinova.ai

: A Case of CCDC6-RET Fusion Mutation in Adult Acute Lymphoblastic Leukemia (ALL), a Known Activating Mutation Unreported in ALL

Researchers

Presenter

  • Mateo Mejia Saldarriaga

Principal Investigators

  • Amir Steinberg

  • Adam F. Binder

Medical Centers

  • Internal Medciine residency, Jacobi Medical Center, Bronx, NY

  • Mount Sinai Medical Center, Larchmont, NY

  • Department of Medical Oncology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Genetic Disorder

  • Endocrine/metabolic Diseases (ME)

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Graft-versus-host disease

  • B lymphoblastic leukemia

  • Type 2 diabetes mellitus

  • Hypothyroidism

  • Diabetes

Biomarkers

  • Alkaline phosphatase

  • B-lymphocyte antigen CD20

  • Breakpoint Cluster Region

  • Cluster of Differentiation 19

  • Cluster of Differentiation 34

  • Cluster of differentiation 45

  • Cyclin Dependent Kinase Inhibitor 2A

  • DNA methyltransferase 3 alpha

  • Fms related tyrosine kinase 3

  • Human Leukocyte Antigen – DR isotype

  • Lactate

  • Lactate dehydrogenase

  • Tumor protein p53

Drug/Treatment

  • Alkaline phosphatase

  • Ruxolitinib phosphate

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved